COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

March 07, 2024



« back to news page